Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Novela italiana
7
Operas
5
Historia
3
Cirugía
2
Cuentos chinos
2
Extractos
2
Oratorios (Música)
2
Robótica
2
Agrobiodiversidad
1
Análisis modal
1
Architectural design
1
Architectural rendering
1
Arroz híbrido
1
Arte chino
1
Arte mexicano
1
Artes Marciales
1
Atlas
1
Ave María (Música)
1
Biotecnología
1
Biotecnología agrícola
1
Boánica
1
Canciones infantiles
1
Canciones sacras
1
Canciones sacras (Voces agudas) y orquesta
1
Cantatas
1
Cartografía
1
Cibernética
1
Cirugía ortopédica
1
Comercio
1
Comunismo
1
-
55561por Yu, Haichuan, Lei, Ting, Su, Xiaojie, Zhang, Lu, Feng, Zhouzhou, Dong, Mengya, Hou, Zheyu, Guo, Hong, Liu, Jian“…Ohba (R. crenulata) and two on Rhodiola kirilowii (Regel) Maxim (R. kirilowii); the remaining five focused on Rhodiola wallichiana (Hook.) S.H.Fu (R. wallichiana). Compared with the placebo, patients who received Rhodiola L. presented no more adverse events (p = 0.65) but showed significant improvement in the percentage of forced expiratory volume in 1 s at prediction (FEV1%pred), forced expiratory volume in 1 s (FEV1), the ratio of forced expiratory volume in 1 s on forced vital capacity (FEV1/FVC), saturation of oxygen in arterial blood, partial pressure of oxygen in arterial blood (PaO(2)), partial pressure of carbon dioxide in arterial blood (PaCO(2)), systolic pulmonary arterial pressure, diastolic pulmonary arterial pressure, COPD assessment test, efficient rate, C-reactive protein, and N-terminal pro-B-type natriuretic peptide (all p < 0.01). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55562“…The top two additive renoprotective collocations of the S herb in compounds were Xue-Fu-Zhu-Yu-Tang and Shen-Tong-Zhu-Yu-Tang, followed by Shu-Jing-Huo-Xue-Tang and Shen-Tong-Zhu-Yu-Tang. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55563por Wei, Po-Li, Huang, Chien-Yu, Chang, Tung-Cheng, Lin, Jang-Chun, Lee, Cheng-Chin, Prince, G. M. Shazzad Hossain, Makondi, Precious Takondwa, Chui, Angelina Wong-Ying, Chang, Yu-Jia“…Moreover, knockout of PCTK1 was observed to increase the resistance of CRC cells to both irinotecan (CPT-11) alone and in combination with 5-fluorouracil (5-FU). Additionally, the fold change of the anti-apoptotic molecules (Bcl-2 and Bcl-xL) and the proapoptotic molecules (Bax, c-PARP, p53, and c-caspase3) was reflected in the chemoresistance of PCTK1-KO CRC cells. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55564por Schmutzer, Michael, Skrap, Benjamin, Thorsteinsdottir, Jun, Fürweger, Christoph, Muacevic, Alexander, Schichor, Christian“…Side effect data included therapy-related morbidity during follow-up (FU). RESULTS: A total of 137 patients (median age, 58.3 years) with SSS meningiomas WHO grade I were analyzed: 51 patients (37.2%) in group 1, 15 patients (11.0%) in group 2, and 71 patients (51.8%) in group 3. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55565por Ploeg, Emily Maria, Britsch, Isabel, van Wijngaarden, Anne Paulien, Ke, Xiurong, Hendriks, Mark Alexander Johannes Martinus, Samplonius, Douwe Freerk, Helfrich, Wijnand“…Additionally, treatment with bsAb CD73xEpCAM potently inhibited the proliferative capacity of OC cells and enhanced their sensitivity to cisplatin, doxorubicin, 5FU, and ionizing radiation. BsAb CD73xEpCAM may be useful in the development of tumor-directed immunotherapeutic approaches to overcome the CD73-mediated immunosuppression in patients with refractory OC.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55566por Sun, Weijing, Veeramachaneni, Nirmal, Al‐Rajabi, Raed, Madan, Rashna, Kasi, Anup, Al‐Kasspooles, Mazin, Baranda, Joaquina, Saeed, Anwaar, Phadnis, Milind A., Godwin, Andrew K., Olyaee, Mojtaba, Streeter, Natalie, Nagji, Alykhan, Dai, Junqiang, Williamson, Stephen“…METHODS: Patients with locally advanced (T1N1‐3M0 or T2‐3NanyM0) potentially resectable esophageal/gastric/GEJ adenocarcinoma by PET/EUS/CT and staging‐laparoscopy, were treated preoperative 4 cycles mFOLFOX6 (Oxaliplatin 85 mg/m(2)/Leucovorin 400 mg/m(2)/5‐FU bolus 400 mg/m(2) then infusion 2400 mg/m(2) for 46 h q2weeks) and 3 cycles pembrolizumab (200 mg q3week). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55567por Cheng, Quan, Liu, Kanghui, Xiao, Jian, Shen, Kuan, Wang, Yuanhang, Zhou, Xinyi, Wang, Jiawei, Xu, Zekuan, Yang, Li“…Furthermore, we identified SEC23A attenuated 5-FU therapeutic effectiveness in gastric cancer cells through autophagy-mediated ER stress relief. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55568“…Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55569por Taieb, Julien, Seufferlein, Thomas, Reni, Michele, Palmer, Daniel H., Bridgewater, John A., Cubillo, Antonio, Prager, Gerald W., Vermeire, Alice, Hédouin-Biville, Fabienne, Teng, Zhaoyang, Macarulla, Teresa“…Frequent second-line therapies were gemcitabine monotherapy (25.0%), fluorouracil (5-FU) + oxaliplatin (21.8%), and gemcitabine + nab-paclitaxel (16.7%). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55570“…In cases with obvious spread of the disease chemotherapy, mostly with 5-FU and leucovorin is advised. Cytoreductive surgery with adjuvant intraperitoneal chemotherapy can offer improved survival in cases with advanced peritoneal dissemination.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55571por Stadler, Peter, Putnik, Kurt, Kreimeyer, Thore, Sprague, Lisa D, Koelbl, Oliver, Schäfer, Christof“…The schedule consisted of one therapy block with 30 Gy in 20 fractions over a two week period with concomitant chemotherapy (d 1–5: 20 mg/m(2)/d DDP + 750–1000 mg/m(2)/d 5FU (cont. infusion). This therapy block was repeated after a fortnight break up to a cumulative dose of 60 Gy and followed by a boost up to 70 Gy (69–70.5 Gy). …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55572“…Existing POL groups at the University of Leipzig and the FU Berlin started using this module for information exchange and serve as content providers. …”
Enlace del recurso
Enlace del recurso
Texto -
55573“…MTX was given in a dose of 1500 mg m-2 intravenously (i.v.) followed after 1 h by 5-FU 1500 mg m-2 i.v. on day 1; leucovorin rescue was started after 24 h (30 mg orally every 6 h for 48 h) and epidoxorubicin 60 mg m-2 i.v. was administered on day 15. …”
Enlace del recurso
Enlace del recurso
Texto -
55574Publicado 1988“…Blast colonies were developed by rIL-3 from the spleen cells of mice pretreated with 5-fluorouracil (5-FU) in the methylcellulose cultures. When such IL-3-induced blast colonies were individually lifted up and recultured in the presence of rIL-3 and recombinant erythropoietin (rEpo), a variety of hematopoietic colonies developed from every single colony, including neutrophils, macrophages, eosinophils, megakaryocytes, mast cells, and erythroblasts. …”
Enlace del recurso
Enlace del recurso
Texto -
55575por Huang, Ming-Yii, Fang, Wei-Yu, Lee, Su-Chen, Cheng, Tian-Lu, Wang, Jaw-Yuan, Lin, Shiu-Ru“…Patients were diagnosed as either high-risk stage II (T2 and 3 N0 M0) or III (any T N1 and 2 M0) and were administered adjuvant chemotherapy regimens that included 5-fluorouracil (5FU) and leucovorin (LV). The correlations between genetic polymorphisms and patient clinicopathological features and relapses were investigated. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55576por Giovannetti, E, Backus, H H J, Wouters, D, Ferreira, C G, van Houten, V M M, Brakenhoff, R H, Poupon, M-F, Azzarello, A, Pinedo, H M, Peters, G J“…Lovo 175X2 cells (transfected with mt p53) were more resistant to 5-fluorouracil (5-FU; 2-fold), nolatrexed (3-fold), raltitrexed (3-fold) and pemetrexed (10-fold) in comparison with the wt p53 parental cells Lovo 92. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55577por Guo, X, Evans, T R J, Somanath, S, Armesilla, A L, Darling, J L, Schatzlein, A, Cassidy, J, Wang, W“…Both CMV- and κB4-CEA205-driven TP cDNA transiently transfected cells were 8- to 10-fold sensitised to 5-fluorouracil (5-FU) prodrug, 5′-deoxy-5-fluorouradine (5′-DFUR), in contrast to only 1.5- to 2-fold sensitised by the κB4- and CEA205-driven TP cDNA-transfected cells. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55578por Miyazono, F, Metzger, R, Warnecke-Eberz, U, Baldus, S E, Brabender, J, Bollschweiler, E, Doerfler, W, Mueller, R P, Dienes, H P, Aikou, T, Hoelscher, A H, Schneider, P M“…We examined the potential of quantitative epidermal growth factor receptor (EGFR, synonym: c-erbB-1) and c-erbB-2 (synonym: HER2/neu) mRNA expression to predict minor or major histopathologic response to neoadjuvant radiochemotherapy (cis-platinum, 5-FU, 36 Gy), followed by radical surgical resection, in patients with oesophageal cancer. …”
Publicado 2004
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55579por Würschmidt, Florian, Dahle, Jörg, Petersen, Cordula, Wenzel, Claudia, Kretschmer, Matthias, Bastian, Christoph“…Inoperable or incompletely resected patients were offered concurrent chemotherapy with either 5-FU or capecitabine. All patients received 3D-conformal radiotherapy with 1.6 to 2.5 Gy/fraction five times weekly. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
55580por Black, William C, Doty, Jeffrey B, Hughes, Mark T, Beaty, Barry J, Calisher, Charles H“…The low π(a )relative to π(s )suggests strong purifying selection and this was confirmed by a Fu and Li analysis. The absolute rate of molecular evolution of the M segment was 6.76 × 10(-3 )substitutions/site/year. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto